This episode explains: Why does Crohn’s disease (chronic enteritis), which confused doctors for 25 years, keep inflaming the gut? A UC team used AI + biology to find the cause—two proteins in the gut don’t bind, breaking the immune "switch."

Key Findings

What’s Crohn’s? Immune cells “fight randomly”
In a healthy gut, immune cells called "macrophages" have two types:

• "Inflammatory type": Attacks harmful bacteria;
• "Restorative type": Repairs the gut after fighting.
  In Crohn’s patients, the "switch" malfunctions—the "inflammatory type" stays active, inflaming even without bacteria, damaging the gut.
• Culprit: Two proteins don’t bind
  We’ve long known patients have NOD2 gene mutation, but not why it causes disease. New findings:
• When healthy, NOD2 (detects bacteria) binds to Guerdon (helps organize cell structure). This makes immune response fast and accurate, and triggers repair after fighting;
• Patients have a deletion in NOD2, so it can’t bind to Guerdon. The "detection-repair" system breaks, and immune cells can only "fight" nonstop.
• AI’s big role: Find clues in massive data
  The team collected thousands of immune cell gene profiles. Finding differences among tens of thousands of genes was impossible for humans. AI screened 53 key genes, pinpointing the "protein non-binding" issue.
• Mouse experiment confirms: No binding = out-of-control inflammation
  Tests on mice with Crohn’s-like symptoms:
• Mice without Guerdon had severe gut inflammation, disrupted microbiomes, even died of sepsis (total immune chaos);
• Proves binding of these two proteins is key to controlling inflammation.
• Good news for patients: Precise treatment direction
  Before, Crohn’s was treated by suppressing the whole immune system with drugs, which had big side effects. Now we know it’s "protein non-binding," future options may include:
• "Molecular bridge" drugs to help mutated NOD2 rebind to Guerdon;
• Gene therapy to fix NOD2’s deletion, solving inflammation at the root, not just relieving symptoms.

Summary

This discovery solves a 25-year puzzle and paves the way for precise Crohn’s treatment. Curious about how AI analyzed data and experiment details? Tune in to the episode!